New Alzheimer’s Treatment Shows Promise in Animal Tests

A team of scientists has discovered a drug that, in mice, seems to stop and partially reverse damage done by Alzheimer’s disease.

Their research was just published in the Proceedings of the National Academy of Sciences following a 10-year study, the Orlando Sentinel says.

The scientists at the Sanford-Burnham Medical Research Institute tried 37 combinations of two existing drugs, nitroglycerin and memantine, before finding one that seemed to have an impact.

Nitroglycerin is used to treat chest pain, while memantine is already used to treat Alzheimer’s but isn’t very effective on its own, the paper says. The combination of the two is known as NitroMemantine.

“In [mice] models, the hybrid appears to restore synapses — the connections between neurons — lost in the disease process,” the Orlando Sentinel says. It begins to work within a few hours and can restore synapses within a few months. The research team believes it is the first drug to do so.

Other scientists agree the research is promising, the paper notes, but it will be several years before trials are conducted on humans.

Alzheimer’s afflicts an estimated 5.2 million people in the U.S., the Alzheimer’s Association says, with a direct national cost of $203 billion a year. About $34 billion of that is out-of-pocket expense.

You can look at the research study here for $10, but it uses phrases like “extrasynaptic NMDA receptors” and “miniature excitatory postsynaptic currents.”

Sign up for our free newsletter

Like this article? Sign up for our newsletter and we'll send you a regular digest of our newest stories, full of money saving tips and advice, free! We'll also email you a PDF of Stacy Johnson's "205 Ways to Save Money" as soon as you've subscribed. It's full of great tips that'll help you save a ton of extra cash. It doesn't cost a dime, so why wait? Click here to sign up now.

Check out our hottest deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 1,186 more deals!

Comments & discussion

We welcome your opinions, but let’s keep it civil. Like many businesses, we reserve the right to refuse service to anyone. In our case, that means those who communicate by name-calling, racism, using words designed to hurt others or generally acting like an uninformed bully. Also, comments that include links to email addresses or commercial websites typically aren't posted. This isn't a place to advertise your business.